TransReco Bio
Wenzhou
About TransReco Bio
TransReco Bio is a one-stop biomacromolecule CDMO service provider that offers full-process CDMO services for eukaryotic and microbial recombinant proteins, nanoantibodies, monoclonal antibodies, bispecific antibodies, small-volume sterile lyophilized powders and aqueous solutions, BFS blow-canned sterile eye drops, and topical sterile gel preparations to domestic and foreign biomacromolecule production and R&D companies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Angel (Nov 2024)
- Website: transrecobio.com
- Phone: +86 0577-85702208
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/transreco-bio-162801 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.